4//SEC Filing
Karydas Daphne 4
Accession 0001933414-24-000020
CIK 0001933414other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:21 PM ET
Size
5.5 KB
Accession
0001933414-24-000020
Insider Transaction Report
Form 4
Karydas Daphne
Director
Transactions
- Award
Stock Option
2024-05-22+22,000→ 22,000 totalExercise: $12.52Exp: 2034-05-22→ Common Stock (22,000 underlying)
Footnotes (1)
- [F1]The stock option award vests in 12 substantially equal monthly installments beginning on June 22, 2024. In the event that the next annual meeting of stockholders occurs prior to May 22, 2025, any remaining unvested portion of the stock option award will vest on the date of such meeting.
Documents
Issuer
Mineralys Therapeutics, Inc.
CIK 0001933414
Entity typeother
Related Parties
1- filerCIK 0001816952
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:21 PM ET
- Size
- 5.5 KB